Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 Modulation
{{output}}
Objectives: Glioblastoma (GB) is the most aggressive type of brain tumor in adults, and the chemical agent temozolomide (TMZ) is widely used for its treatment. However, TMZ resistance can lead to therapeutic failure. The aim of t... ...
